B2M and Alzheimer disease: In contrast to other serum and CSF biomarkers, result from Bayesian graphical network analysis, a study based on three previously identified collections of multiple AD biomarkers, revealed that B2M was at the central node within the network and exhibited the highest number of connections to other proteins (Rembach et al. 2015).